Infections in patients with chronic kidney disease

被引:22
作者
Foley, Robert N. [1 ]
机构
[1] Univ Minnesota, Dept Nephrol, Chron Dis Res Grp, Minneapolis, MN 55404 USA
关键词
D O I
10.1016/j.idc.2007.06.005
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
There has been a notable lack of research activity regarding major infections in patients with advanced chronic kidney disease. To an outsider, this might seem unexpected, because uremia has long been considered a state of immune hyporesponsiveness and rates of major bacterial infection, like septicemia and pneumonia, are known to be orders of magnitude more likely in dialysis populations than in the general population. This article reviews recent literature on the topic, focusing predominantly on the clinical epidemiology of major bacterial infections in dialysis patients, the links between bacterial infections and cardiovascular disease, and randomized trials of interventions designed to prevent these infections.
引用
收藏
页码:659 / +
页数:15
相关论文
共 72 条
[1]   Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care [J].
Angus, DC ;
Linde-Zwirble, WT ;
Lidicker, J ;
Clermont, G ;
Carcillo, J ;
Pinsky, MR .
CRITICAL CARE MEDICINE, 2001, 29 (07) :1303-1310
[2]  
Dooley Samuel W., 2008, Morbidity and Mortality Weekly Report, V57, P1
[3]  
Bending M, 1996, J AM SOC NEPHROL, V7, P2403
[4]   A randomized trial of Staphylococcus aureus prophylaxis in peritoneal dialysis patients: Mupirocin calcium ointment 2% applied to the exit site versus cyclic oral rifampin [J].
Bernardini, J ;
Piraino, B ;
Holley, J ;
Johnston, JR ;
Lutes, R .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1996, 27 (05) :695-700
[5]   Randomized, double-blind trial of antibiotic exit site cream for prevention of exit site infection in peritoneal dialysis patients [J].
Bernardini, J ;
Bender, F ;
Florio, T ;
Sloand, J ;
PalmMontalbano, L ;
Fried, L ;
Piraino, B .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (02) :539-545
[6]  
Brignt R., 1836, GUYS HOSP REP, V10, P338
[7]  
BURKART JM, 1990, PERITON DIALYSIS INT, V10, P41
[8]  
*CAPD, 1989, PERITON DIALYSIS INT, V9, P159
[9]   Effect of short-term treatment with azithromycin on recurrent ischaemic events in patients with acute coronary syndrome in the Azithromycin in Acute Coronary Syndrome (AZACS) trial: a randomised controlled trial [J].
Cercek, B ;
Shah, PK ;
Noc, M ;
Zahger, D ;
Zeymer, U ;
Matetzky, S ;
Maurer, G ;
Mahrer, P .
LANCET, 2003, 361 (9360) :809-813
[10]   Hospital-acquired infections among chronic hemodialysis patients [J].
D'Agata, EMC ;
Mount, DB ;
Thayer, V ;
Schaffner, W .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 35 (06) :1083-1088